Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126824 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Addition of Steroids on Duration of Analgesia
A Early Phase 1 study of Uterine Fibroids and Adenomyosis, sponsored by University of California, Los Angeles.
- Active
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT04126824 is a Early Phase 1 study of Uterine Fibroids and Adenomyosis that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 28 participants, below the 241-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04126824, a Early Phase 1 study of Uterine Fibroids and Adenomyosis, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Triamcinolone
- OTHER Iohexol contrast
Study Locations (2)
California
- University of California, Los Angeles - Westwood, Los Angeles
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2027-08-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04126824
The ClinicalTrials.gov registry entry for NCT04126824 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (88% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Uterine Fibroids appearing as the primary indexed condition, and to 3 interventions - of which Bupivacaine is the first listed.
NCT04126824 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04126824 about?
NCT04126824 is a clinical study titled "Effect of Addition of Steroids on Duration of Analgesia". The purpose of the study is to investigate the differences in post-procedural pain scores and narcotic use among patients who receive a Superior Hypogastric Nerve Block (SHNB) with and without corticosteroid performed as part of the Uterine Artery Embolization (UAE) procedure.
What is the current status of trial NCT04126824?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2022-01-06. Estimated completion is 2027-08-02.
What conditions does trial NCT04126824 study?
This clinical trial studies the following conditions: Uterine Fibroids, Adenomyosis.
What interventions are being tested in trial NCT04126824?
The interventions under investigation include: Bupivacaine (DRUG), Triamcinolone (DRUG), Iohexol contrast (OTHER).
Who is sponsoring clinical trial NCT04126824?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126824 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
ACTIVE NOT RECRUITING
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation
COMPLETED · NA
-
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
COMPLETED · Phase 2
-
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.